SOD2 and cancer: GClnc1 promotes cancer progression by partially activating MYC; MYC mRNA levels were significantly increased on GClnc1 overexpression and significantly decreased after GClnc1 silencing [342]; hence, MYC and GClnc1 levels are positively correlated.